Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2021-09-08 00:00:00 ET · period of report 2021-09-07 · accession 0001628280-21-018219 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-08 | 2021-09-07 | AUPH | Martin Michael Robert | Chief Business Off | S - Sale | $18.10 | -7,500 | 176.9K | -4% | -$135.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | S | D | 7,500 | $18.10 | 176,861 | D | — | — |